Crystal structure of human cytochrome P450 2C9 with bound warfarin (Q27641685)

object named as

Dijana Matak Vinković

0 references

author name string

Pamela A Williams

0 references

Jose Cosme

0 references

Alison Ward

0 references

Hayley C Angove

0 references

Harren Jhoti

Cytochromes P450 and metabolism of xenobiotics

0 references

language of work or name

English

0 references

publication date

24 July 2003

0 references

published in

Nature

0 references

volume

424

0 references

issue

6947

0 references

page(s)

464-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Conformational dynamics in cytochrome P450-substrate interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Crystal structure of cytochrome P‐450cam complexed with the (1S)‐camphor enantiomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Crystal structure of cytochrome P450 14 -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Pivotal role of water in the mechanism of P450BM-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Development of a combined protein and pharmacophore model for cytochrome P450 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Pharmacogenetics of warfarin elimination and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Human P450 metabolism of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Allosteric phenomena in cytochrome P450-catalyzed monooxygenations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

AMoRe: an automated package for molecular replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An Approach Using Designed Tienilic Acid Derivatives and Molecular Modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

The catalytic mechanism of cytochrome P450 BM3 involves a 6 Å movement of the bound substrate on reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a Substrate of Cytochrome P450 2D6: Allosteric Effects of NADPH−Cytochrome P450 Reductase†

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

ADMET--turning chemicals into drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

7 January 2021

Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole activity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

7 January 2021

Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

7 January 2021

On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

7 January 2021

Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01862

7 January 2021